Immunovant, Inc.
NASDAQ:IMVT · NASDAQ Global Select
+$0.69 today
Vol 3.20M · Avg 1.84M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+128.44%
Period High
$35.56
Period Low
$14.69
Latest
$35.34
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Kymera Therapeutics, Inc.
NASDAQ:KYMR
$7.49B
Praxis Precision Medicines, Inc.
NASDAQ:PRAX
$5.99B
Akero Therapeutics, Inc.
AKRO
$4.50B
Crinetics Pharmaceuticals, Inc.
NASDAQ:CRNX
$3.83B
ACADIA Pharmaceuticals Inc.
NASDAQ:ACAD
$3.70B
Viking Therapeutics, Inc.
NASDAQ:VKTX
$3.63B
NewAmsterdam Pharma Company N.V.
NASDAQ:NAMS
$3.62B
Dyne Therapeutics, Inc.
NASDAQ:DYN
$3.30B
Ultragenyx Pharmaceutical Inc.
NASDAQ:RARE
$2.77B
Soleno Therapeutics, Inc.
SLNO
$2.76B
What is the latest IMVT filing?
The latest filing shown is 4 dated Jun 16, 2026.
How many recent filings does IMVT have?
Intrinsic Alpha currently shows 20 recent filings for IMVT.
Explore More
Continue the stock analysis
Jump to another research area for this company.